Fanconi anemia (FA/BRCA) signaling network controls multiple genome-housekeeping checkpoints, from interphase DNA repair to mitosis. The in vivo role of abnormal cell division in FA remains unknown. Here, we quantified the origins of genomic instability in FA patients and mice in vivo and ex vivo. We found that both mitotic errors and interphase DNA damage significantly contribute to genomic instability during FA-deficient hematopoiesis and in nonhematopoietic human and murine FA primary cells. Super-resolution microscopy coupled with functional assays revealed that FANCA shuttles to the pericentriolar material (PCM) to regulate spindle assembly at mitotic entry. Loss of FA signaling rendered cells hypersensitive to spindle chemotherapeutics and allowed escape from the chemotherapy-induced spindle assembly checkpoint. In support of these findings, direct comparison of DNA cross-linking and antimitotic chemotherapeutics in primary FANCA−/− cells revealed genomic instability originating through Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
INTRODUCTION
Fanconi anemia (FA/BRCA) pathway is an intricate plexus of at least 17 proteins that maintain genomic stability, control growth and development, and prevent cancer. Bi-allelic germline disruption of any FA gene causes Fanconi anemia (FA), a genetic disorder characterized by developmental abnormalities, bone marrow failure (BMF), myelodysplasia and high risk of cancer, particularly acute myeloid leukemia (AML) [1] [2] [3] [4] [5] . Heterozygous inborn mutations in the BRCA branch of FA network increase risk of breast and ovarian cancers as well as other tumors [5] [6] [7] [8] [9] , and somatic mutations of FA/BRCA genes occur in malignancies in non-Fanconi patients [10] [11] [12] [13] . Thus, disruption of FA/BRCA signaling promotes malignancies in the inherited genetic syndromes and in the general population.
The FA/BRCA pathway prevents cancer by protecting genome integrity. In interphase, DNA damage response (DDR) initiates the assembly of the multi-protein FA complex at damage sites to arrest the cell cycle as the cascade of effectors repairs the lesions 1, 5 . These compartmentalized bursts of FA activity handle multiple genotoxic insults, from endogenous aldehydes 14, 15 to replication errors and mutagen exposure. Thus, the FA/BRCA network provides a crucial line of defense against interphase mutagenesis 1, 5 .
Less is known about the role of the FA/BRCA pathway during mitosis, but FA signaling has been recently implicated in the maintenance of normal centrosome count [16] [17] [18] [19] , spindle assembly checkpoint (SAC) 17, 20 , repair of anaphase bridges 21, 22 and execution of cytokinesis [23] [24] [25] . Since chromosomal instability due to mitotic errors is a hallmark of cancer 26, 27 and a therapeutic target 28 , these findings may have translational relevance. However, it is unknown whether these ex vivo observations are applicable to in vivo hematopoiesis.
Here, we present quantitative evidence that loss of FA signaling disrupts mitosis during in vivo hematopoiesis in humans and mice, and that both aberrant interphase and mitotic failure contribute to genomic instability due to FA deficiency. Super-resolution microscopy revealed that FANCA shuttles to the pericentriolar material at mitotic entry to regulate centrosome-associated spindle nucleation. We found that primary FANCA−/− cells escape chemotherapy-induced SAC to replicate despite genomic instability. Our cell-survival assays showed that FA-deficient cells are hypersensitive to taxol (an antimitotic chemotherapeutic). Sublethal taxol doses exacerbated genomic instability in FA−/− cells through mitotic errors while low-dose MMC activated the G2/M checkpoint and DNA breakage. Therefore, distinct classes of chemotherapeutics inflict unique damage patters in FA−/− cells, which may have implications for future strategies against FA-deficient cancers. Together, our findings provide insights into complex mechanisms of genomic instability in FA.
METHODS

Cell culture
The primary patient fibroblast cells, FANCA−/− (MNHN, RA885), and FANCC−/− (WD-C1, homozygous for FANCC c.377_378delGA ), were received from Dr. Helmut Hanenberg (IU). MNHN cells harbor two FANCA mutations: c.3163C>T, and c.4124-4125delCA. Both FANCA-deficient lines have been published 17 . Most experiments were done using the MNHN cells unless otherwise noted. Fibroblasts and MEFs were cultured in DMEM containing 10% fetal bovine serum (FBS), 1% penicillin-streptomycin (pen-strep), and 1% sodium pyruvate in 37°C-5%CO 2 -5%O 2 incubators to minimize oxidative damage. Primary human CD34+ cells (IU Simon Cancer Center Angio BioCore) were incubated at 37°C-5%CO 2 -5%O 2 in IMDM with 20% FBS, 1% pen-strep, 100 ng/ml SCF, 100ng/ml TPO, and 100ng/ml FLT3.
Mice
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at IU School of Medicine. Fancc−/− mice 29 were a gift from Dr. D. Wade Clapp (IU).
RBC micronucleation assays
50 µls of blood were collected from the murine lateral tail vein into EDTA-coated collection tubes containing methanol (2 mls, pre-chilled at −80°C for >1hr) and stored in −80°C. Next, 10ml PBS was added, cells were pelleted at 600×g (5 minutes, 4°C). The supernatant was aspirated and RBCs were resuspended in residual methanol/PBS. 20 µl aliquots were transferred to flow tubes and incubated in the dark with 90 µls of FITC-conjugated antimouse CD71 (Biolegend)+1 mg/ml RNAse A (Roche) first for 30 minutes at room temperature (RT) and then 30 minutes on ice. Propidium iodide staining (Invitrogen) at 1.25 µg/ml was followed by flow cytometry on a FacsCalibur machine (Becton-Dickinson). At least 500,000 events/sample were acquired. Hemavet 950FS (Drew Scientific) was used for blood counts.
Deconvolution and super-resolution microscopy
Cells grown on ultrafine glass coverslips (Fisher) were fixed with 4% paraformaldehyde/PBS for 15 minutes (RT), PBS-washed, permeabilized with 0.1% Triton X-100/PBS for 10 minutes, PBS-washed, blocked in 5% bovine serum albumin (BSA)/PBS or ImageIT SignalEnhancer (Life Technologies) for 1 hour, and then incubated in primary antibody in 1% BSA/PBS overnight (4°C) or 2 hours (RT). Antibodies are listed in Supplemental Information. Next, cells were PBS-washed and incubated with secondary antibodies (1:2000, 1% BSA/PBS) for 30 minutes (RT), PBS-washed, counterstained with Hoechst-33342 (Life Technologies) in PBS (1:10,000) for 10 minutes, washed and mounted in SlowFade Antifade (Life Technologies).
For deconvolution microscopy, image stacks (z-section distance: 0.2µm) were acquired on a Deltavision personalDx microscope (Applied Precision) with a CCD camera using 20×, 60× or 100× lenses, and deconvolved using Softworx. Super-resolution structured illumination microscopy (SR-SIM) images were acquired on a Zeiss ELYRA PS.1 system with a CCD camera and 60×/100× lenses, and processed via SIM/channel-alignment algorithms (Zen-2011; Zeiss). Line-intensity profiles were quantified using Imaris (Bitplane). Zsections shown on figures were exported using Imaris.
Images of FA patient marrow aspirates, marrow aspirates of patients diagnosed with immune-mediated aplastic anemia with negative chromosome breakage test results, marrow cytospins and peripheral smears were obtained on Zeiss Axiolab microscope with Axiocam-105 color camera.
Cytokinesis-block micronucleus assays
Fibroblasts and MEFs grown on coverslips were treated with cytochalasin B (2µg/ml) for 24 hours followed by processing/imaging as above; anti-CENPA immunofluorescence visualized endogenous kinetochores. For drug treatments, cells were exposed to 1nM taxol or MMC for 9 days before cytochalasin B for 24 hrs. A micronucleus was defined based on the following criteria: (1) the diameter of the micronucleus must be less than ½ of the main nucleus and (2) nuclear boundary must be identified between the micronucleus and the nucleus. The presence of kinetochores was determined based on visualization of CENPA+ foci within the stack of z-sections spanning the entire micronucleus.
For CD34+ experiments, primary human CD34+ cells transduced with GFP-tagged lentiviral shRNA constructs were cultured for 5 days, sorted on a SORPAria FACS system, attached to coverslips via cytospin (450rpm, 7 minutes), and analyzed in immunofluorescence assays as above.
Mitotic spindle assembly assay
Culture plates with live fibroblasts on coverslips were removed from the 37°C incubator to replace growth medium with pre-chilled medium and kept in 4°C (1 hour). Next, the cold medium was replaced with pre-warmed medium (37°C), cells were returned to 37°C (15 seconds), and immediately fixed (4% paraformaldehyde/PBS). Upon staining with antipericentrin and anti-α-tubulin, cells were imaged via deconvolution microscopy. Imaris (Bitplane) was used to measure length of microtubules in z-sections and count centrosomeassociated microtubules within stacks.
Statistics
Statistical analyses were performed using GraphPad Prism 6; p<0.05 was considered significant.
Study approval
Patients had been enrolled on the IRB-approved protocol at IU School of Medicine (IRB#1108006474). All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at IU School of Medicine.
RESULTS
In vivo error-prone mitosis during FA−/− hematopoiesis
Mitotic failure was reported in FA cells ex vivo, and cytokinesis failure was documented in FA marrows 17, 23 . However, the in vivo evidence of abnormal early mitosis in hematopoietic cells of FA patients has been missing. To examine whether loss of FANCA (the gene most commonly disrupted in FA 5 ) predisposes hematopoietic cells to erratic divisions in vivo, we quantified mitotic errors in marrow aspirates of two FANCA−/− patients with pancytopenia but no MDS/AML. Consistent with the role of FANCA in cell division, we observed increased frequency of abnormal mitotic figures in FANCA−/− marrows compared to marrow aspirates of patients diagnosed with immune-mediated aplastic anemia after excluding FA by negative chromosome breakage tests ( Figure 1A , p=0.01). Lack of chromosome congression leading to lagging chromosomes in anaphase and micronucleation at mitotic exit reflects weakened SAC or merotelic attachment due to centrosome malfunction 17 . The DNA bridges in late mitosis may reflect impaired resolution of ultrafine anaphase bridges 21 . Interphase nuclear morphology in the erythroid lineage provided further evidence of in vivo mitotic abnormalities ( Figure 1B-C) . Erythroblast micronucleation ( Figure 1B ) suggests failure to segregate chromosomes into the daughter nuclei. Presence of bizarre erythroblasts with multilobed nuclei ( Figure 1B ) is consistent with impaired chromosome segregation due to erroneous SAC followed by cytokinesis failure 17, 23 . Binucleated erythroblasts ( Figure 1B ) reflect lack of cytokinesis after normal chromosome division 23 . These results provide quantitative in vivo evidence that abnormal mitoses occur with increased frequency in the hematopoietic cells of FANCA−/− patients before development of MDS/AML.
We next validated these findings in a different in vivo experimental system. We examined hematopoietic chromosomal instability in living Fancc−/− mice using an in vivo erythrocyte micronucleation assay 30, 31 . This assay is based on the notion that genomically unstable orthochromatic erythroblasts fail to extrude micronuclei, producing micronucleated red blood cells (RBCs). Indeed, we observed micronucleated RBCs in FA patients' marrows ( Figure 1C ). These micronucleated RBCs are identified via flow cytometry as DNAcontaining CD71− RBCs ( Figure 1D ). 3-month old Fancc−/− mice released almost threefold more micronucleated mature RBCs into the peripheral blood compared to age-matched controls ( Figure 1D , p<0.0001). Importantly, blood counts demonstrated no differences between the age-matched wt and Fancc−/− mice (Supplemental Table 1 ). Thus, disruption of two different FA core genes (FANCA and Fancc) leads to chromosomal instability during in vivo hematopoiesis in humans and mice before the onset of clinically significant BMF, myelodysplasia or leukemia.
A combination of interphase and mitotic errors drives genomic instability in FA
Since BMF and hematopoietic malignancies are consistent clinical hallmarks of FA 1,5 , we quantified the contribution of interphase and mitotic abnormalities to genomic instability in FANCA-deficient hematopoietic cells. A modified micronucleus assay ( Figure 2A ) 32 allowed to determine the origin of multinucleation in primary human CD34+ hematopoietic cells transduced with an shRNA against FANCA 17 compared to control CD34+ cells. We validated the FANCA shRNA in human CD34+ cells ( Figure 2B-C) . Upon FANCA knockdown, CD34+ cells were immunostained for endogenous CENPA (a kinetochore marker 33 ) and imaged by deconvolution microscopy to classify cells based on the presence of CENPA+ foci. As described 32 , additional kinetochore-positive nuclei arise through whole-chromosome missegregation in mitosis, and supernumerary kinetochore-negative nuclei result from DNA fragmentation (Figure 2A ). FANCA-knockdown CD34+ cells developed higher multinucleation due to both chromosome breakage (p=0.0083) and faulty chromosome segregation (p=0.0001) compared to control CD34+ cells ( Figure 2D -E). We concluded that silencing FANCA impairs both interphase and mitotic genome maintenance in human hematopoietic cells.
To validate this finding in primary FA-deficient patient cells and eliminate the possibility of non-specific shRNA-induced phenotype 34 , we pursued cytokinesis-block cytome assays 32 . Dividing cells are treated with cytochalasin B (a cytokinesis inhibitor) prior to CENPA immunofluorescence. Inhibition of cytokinesis generates binucleated cells upon error-free chromosome partition, and the presence of micronuclei indicates abnormal chromosome segregation during the last mitosis. Again, CENPA-positivity distinguishes mitotic-failure micronuclei from DNA-breakage micronuclei ( Figure 3A ) 35 .
FANCA−/− fibroblasts had increased frequency of both chromosome missegregation (p=0.0391) and chromosome breakage (p=0.0218) compared to isogenic gene-corrected cells ( Figure 3B -C). Similarly, Fancc−/− MEFs demonstrated an increased incidence of micronucleation resulting from both chromosome breakage (p=0.0004) and chromosome missegregation (p=0.078) compared to wt MEFs ( Figure 3D -E). Thus, disruption of FA signaling impairs interphase and mitotic fidelity not only during hematopoiesis (Figure 2 ), but also in fibroblasts and MEFs (Figure 3 ). These findings suggest that multiple FA/BRCA proteins may play evolutionarily conserved roles in mitotic genome housekeeping.
FANCA regulates centrosome-mediated spindle microtubule assembly in early mitosis
We and others have reported defects in centrosome amplification in cells lacking the FA/ BRCA pathway [16] [17] [18] [19] , but the impact of FA signaling on mitotic centrosome function per se has not been studied. At mitotic entry, maturing centrosomes nucleate microtubules to build the mitotic spindle 36 . These microtubules undergo controlled rearrangements to properly capture kinetochores before anaphase begins 37 . Since FANCA localizes to the mitotic apparatus 16, 17 and FA signaling is implicated in the SAC 17 , we wondered whether FANCA regulates the dynamic equilibrium of spindle microtubule assembly in early mitosis. We quantified the ability of primary patient-derived FANCA−/− and FANCA+ fibroblasts to establish spindles in modified spindle assembly assays ( Figure 4A ) 38 . Live cells were first placed at 4°C to destabilize microtubules ( Figure 4B ) and then given pre-warmed growth medium to stimulate spindle regrowth, fixed and analyzed via quantitative deconvolution microscopy. Prometaphase FANCA−/− centrosomes demonstrated impaired spindlenucleating ability evidenced by decreased number of microtubules emanating from each centrosome ( Figure 4C-D, p≤0 .0001). The spindle microtubules nucleated by FANCA−/− centrosomes were shorter ( Figure 4E , p≤0.0001) than microtubules assembled in genecorrected cells. Importantly, FANCA−/− cells containing supernumerary centrosomes 16, 17 were excluded from the analysis. Therefore, FANCA is essential not only for the maintenance of centrosome number, but also for efficient mitotic spindle assembly. Superresolution structured illumination microscopy (SR-SIM) revealed endogenous FANCA on mitotic centrosomes in close proximity of spindle microtubules ( Figure 4F-G) , consistent with the role of FANCA in spindle dynamics.
FANCA shuttles to the pericentriolar material during mitotic centrosome maturation
Multiple FA proteins, including FANCA ( Figure 4F-G) , localize to centrosomes and mitotic spindles [16] [17] [18] . However, it is unknown whether FANCA association with centrosomes changes between interphase and mitosis, as expected of a bona fide regulator of mitotic centrosome/spindle function 39, 40 .
Centrosome maturation prepares centrosomes for mitosis through reorganization of the pericentriolar material (PCM). A phosphosignaling circuit of cyclin-dependent kinases (CDKs), polo-like kinase 1 (PLK1) and Aurora A 41 recruits pericentrin 39 and γ-tubulin 40 to the PCM at mitotic entry to increase the spindle-nucleating centrosome activity 42 . Since FANCA regulates spindle assembly ( Figure 4B -E), we wondered whether FANCA is recruited to the PCM of maturing centrosomes similar to these other centrosome-spindle regulators. To examine FANCA sub-centrosomal localization, we employed deconvolution and super-resolution microscopy, which allows visualization of centrosomes beyond the diffraction limit imposed by conventional microscopes 43, 44 . At mitotic entry, FANCA shuttled from centrioles towards the PCM and co-localized with pericentrin, γ-tubulin and the minus end of spindle microtubules until the mitotic exit ( Figure 5A To thoroughly analyze FANCA distribution within the PCM, we analyzed individual 84-nmthin super-resolution sections of mitotic centrosomes. At the mid-centrosome level, we observed well-organized FANCA fibers extending through and beyond the pericentrindecorated PCM network from centrioles towards microtubule nucleation sites ( Figure 5B-C) . This dynamic relocalization of FANCA to the PCM during mitosis supports the newly discovered role of FANCA in spindle microtubule nucleation (Figure 4) .
Loss of FANCA allows escape from SAC arrest and apoptosis
The FA/BRCA pathway repairs interphase DNA damage 45, 46 and participates in the spindle assembly checkpoint (SAC) 17 . To examine the fate of FANCA-deficient cells upon SAC activation, we employed time-lapse imaging of primary FANCA−/− and gene-corrected cells treated with taxol, a microtubule-stabilizing chemotherapeutic ( Figure 6A ). As described in other cells 47, 48 , FANCA-corrected, taxol-exposed cells entered prolonged prometaphase arrest followed by cell death without exiting mitosis. FANCA−/− cells were more likely to escape taxol-induced SAC arrest and generate multinucleated interphase-like cells (p=0.0215; Figure 6B -E). These findings validate the role of FANCA in the SAC and show that loss of FANCA facilitates the escape of chromosomally unstable cells from mitotic death caused by unsatisfied SAC 47 .
FANCA−/− cells are hypersensitive to taxol
A significant fraction of multinucleated cells that escape taxol-induced arrest 49 or form upon failed mitosis 50, 51 is physiologically eliminated to prevent genomic instability 26, 52 . Complete SAC disruption causes chromosomal instability incompatible with cell survival 53 . Thus, we hypothesized that loss of FANCA may render cells hypersensitive to taxol.
Since previous studies evaluating response of FA−/− cells to anti-mitotic chemotherapeutics generated conflicting data 16, 54 , we performed rigorous dose-response experiments to thoroughly examine this concept. We found that two separate FANCA−/− primary patient cell lines harboring different FANCA mutations are hypersensitive to taxol; stable FANCA expression rescued taxol hypersensitivity in both lines in two independent cell viability assays ( Figure 6F-H, Supplemental Figures 7-8) . Likewise, FANCC−/− primary fibroblasts displayed taxol hypersensitivity compared to FANCC-corrected cells (Supplemental Figure  8C) . As expected 1, 5 , FANCA−/− and FANCC−/− cells showed decreased survival upon exposure to the crosslinking agent mitomycin C (MMC) (Figure 6F-H; Supplemental  Figures 2,9 ). These findings, together with previously published work 16 , indicate that loss of FANCA or FANCC is synthetically lethal with exposure to anti-mitotic chemotherapeutics.
Chemotherapy-exposed FANCA−/− cells develop distinct patterns of genomic instability due to separate interphase and mitotic checkpoint abnormalities
Having established the hypersensitivity of FA−/− cells to interphase DNA crosslinkers and anti-mitotic agents, we wanted to understand how loss of FANCA confers hypersensitivity to these separate classes of chemotherapeutics. Thus, we examined cell cycle and patterns of genomic instability in primary FANCA−/− and gene-corrected cells at baseline (Supplemental Figure 10 ) and upon treatment with sublethal doses of MMC and taxol. We selected drug doses that decreased growth of FANCA−/− cells compared to isogenic FANCA+ cells without fully arresting FANCA−/− cells or inducing cell death evidenced by increased sub-G1 fraction on flow cytometry ( Figure 7A and not shown).
Prolonged treatment with 1 nM MMC reduced growth of FANCA−/− cells due to persistent activation of the G2/M checkpoint (p=0.0376) reflected by decreased DNA replication (p<0.0001) and decreased G1 fraction (p=0.0029) (Figure 7A-D) . This observation is consistent with the exaggerated MMC-induced G2/M arrest of FA cells due to the DDR failure 45, 46 . In further support of this notion, exposure to low-dose MMC increased multinucleation due to DNA breakage (p=0.0223) but not chromosome missegregation ( Figure 7E-G (Figure 6 ). Furthermore, low-dose taxol increased multinucleation of FANCA −/− patient cells (p=0.002) secondary to mitotic chromosome missegregation (p<0.0001) as well as chromosome breakage (p=0.0059) ( Figure 7J-K) . Interestingly, multinucleated cells continued to enter S-phase (Supplemental Figure 11) 52 , 55 .
In summary, these results (i) provide evidence that both impaired DDR and error-prone mitosis contribute to chromosomal instability in FANCA−/− cells in vivo and ex vivo, (ii) offer insights into the role of FA pathway in the response to DNA-crosslinking agents and anti-mitotic chemotherapeutics, and (iii) open potential new inroads towards synthetic lethal chemotherapy against FA-deficient cancers.
DISCUSSION
Disrupted FA/BRCA signaling causes genomic instability and cancer. The FA/BRCA tumor suppressor network orchestrates interphase DDR and DNA replication 1, 5 . Multiple lines of evidence implicated FA/BRCA signaling in centrosome maintenance and mitotic checkpoints [16] [17] [18] [19] 21, 23 , but the in vivo importance of these findings is unknown. We found that both abnormal interphase and error-prone mitosis significantly contribute to the in vivo hematopoietic genomic instability in FA−/−humans and mice, suggesting a role for the FA/ BRCA network in genome surveillance throughout the cell cycle ( Figure 7L ).
FANCA−/− patients' hematopoiesis is afflicted by mitotic errors. Lagging chromosomes due to an in vivo SAC impairment 17 and persistent anaphase/telophase bridges 21 Table 1 ), suggesting that impaired mitosis may contribute to carcinogenesis in FA. Indeed, FISH analysis detected chromosomally unstable clones in 15% of FA patients with morphologically normal marrows 56 , and gross chromosomal instability is a hallmark of MDS/AML in FA 57 . More research is needed to quantify the impact of haphazard mitosis on FA-associated myelodysplasia and cancer.
The irregular mitosis during FA−/− hematopoiesis is a consistent but relatively rare event (Figures 1-2) . Further, while multinucleated cells with centrosome clusters are easily seen in FA-deficient cancer cells 17 , multinucleation in FA−/− primary cells is more subtle (Figures  2-3) 17 , perhaps because cancers cannot eliminate mis-dividing cells through backup checkpoints. Indeed, centrosome abnormalities induce TP53-dependent cell cycle arrest 51 and apoptosis 50 , and activation of TP53 contributes to BMF in FA 58 . TP53 inactivation boosts hematopoiesis but promotes MDS/AML in FA 59 , and AML with bizarre karyotype instability occurred in an FA patient with somatic loss of heterozygosity of the TP53-harboring region of chromosome 17 60 . Thus, aneuploidy and centrosome disruption upon inactivation of the FA/BRCA signaling may trigger TP53-dependent checkpoints to limit the risk of leukemia at the cost of BMF.
The role of FANCA in mitosis is not clearly defined. Impaired FA signaling promotes accumulation of centrosomes due to DDR-induced centrosome over-replication 18, 19 and deregulated mitosis 17, 23 . Supernumerary centrosomes promote chromosomal instability through multiple mechanisms 26, 61 . We found that FANCA regulates centrosome-associated spindle assembly (Figure 4) , and FANCA shuttles from centrioles to the PCM spindle attachment sites at mitotic entry (Figures 4-5) . Dissecting FANCA-dependent mitotic centrosome-microtubule-kinetochore interactions in more detail will help understand how FANCA regulates the SAC 17 . We hypothesize that functional and numerical centrosome abnormalities in FA-deficient cells may further promote chromosomal instability by promoting merotelic kinetochore attachment to spindle microtubules; this mechanism of genomic instability has been elucidated in non-FA cells acquiring supernumerary centrosomes 61, 62 . Interestingly, FANCA is phosphorylated by the NIMA-related kinase 2 (NEK2) 16 and AKT kinase 63 ; FANCJ and FANCD1 may regulate polo-like kinase 1 (PLK1) 18, 19 , which is essential for spindle function 64 ; and FANCC binds the key mitotic cyclin-dependent kinase 1 (CDK1) 65 , which co-immunoprecipitates with the FA core complex 66 . Moreover, loss of FANCA is synthetic lethal with PLK1 knockdown 67 and CDK inhibitors disrupt IR-induced formation of FANCD2 foci 68 . Future work will examine these pathway connections to evaluate their translational relevance in cancer and FA.
We found that loss of FA signaling is synthetically lethal with taxol exposure, highlighting the role of FA-dependent SAC in cell survival. Kim et al observed hypersensitivity of FANCA-knockdown cells to nocodazole 16 . Taxol and nocodazole are mechanistically different 69 : nocodazole disrupts spindle-kinetochore attachment, while taxol renders the attached microtubules unable to stretch the kinetochores. Since the FA pathway is essential for taxol-and nocodazole-induced SAC 17 , FANCA may regulate SAC by intra-kinetochore tension.
Of note, others have found that FANCG/FANCC-deficient pancreatic cancer cells exposed to taxol accumulate DNA at similar rate as gene-corrected cells in in vitro fluorescence assays 54 , and concluded that FA−/− cells are not hypersensitive to antimitotics. However, FA−/− cells multinucleate ( Figure 6 ) 16, 17 and replicate (Supplemental Figure 11 ) upon exposure to antimitotics, suggesting why cell growth assays quantify taxol response with better specificity than total DNA measurements. Interestingly, low-dose taxol promotes chromosome missegregation and DNA breaks in FANCA−/− cells. Consistent with this notion, the Pellman group demonstrated that micronuclei produced by mitotic errors undergo excessive mutagenesis 52 with secondary chromosome breakage 55 due to erratic replication. The micronucleus-associated chromosome breakage may be further exacerbated by failed DDR in FANCA−/− micronuclei.
Micronucleation has been noted in FA for decades 70, 71 , but it was unclear whether it reflects interphase abnormalities or erratic mitoses. We addressed this question with quantitative high-resolution-imaging-based micronucleation assays validated in previous studies 32 . Given the key role of FA signaling in interphase 1,5 , we have made effort to confirm that kinetochore-containing micronuclei are not produced simply by impaired DDR. Importantly, DNA-crosslinking agent (MMC) produced "DNA breakage" micronuclei but not "chromosome missegregation" micronuclei ( Figure 7F-G) , confirming the assay's specificity and sensitivity in distinguishing interphase from mitotic errors. Thus, we concluded that genomic instability results from DNA breakage and chromosome missegregation in multiple FA−/− hematopoietic and non-hematopoietic cell types (Figures  2-3) . Based on these and other findings 17 , we propose that FANCA deficiency causes genomic instability through a dual mechanism of impaired interphase DDR/replication and defective mitosis 72 ( Figure 7L ). This model explains the FA-associated patterns of genetic instability and hypersensitivity to both DNA-crosslinkers and antimitotics. Interphase errors exacerbate mitotic abnormalities and mitotic failure promotes interphase mutagenesis. Chromatid remnants generated through impaired DDR or replication are randomly segregated in mitosis. Defective midbody constriction 25 and cytokinesis 23 may shatter lagging chromosomes resulting from impaired SAC 17, 73 and break unresolved anaphase bridges 21, 22 . After mitotic exit, cells may attempt to repair splintered DNA through chromothripsis, the mutagenic process of randomly reconnecting chromosome fragments via non-homologous end joining (NHEJ) [74] [75] [76] . Since FA−/− cells favor error-prone NHEJ over homologous recombination 77 , chromothripsis may have a particularly detrimental impact on genomic stability upon loss of the FA/BRCA network.
Our observations unveil the translational importance of mitotic defects caused by loss of FA/ BRCA signaling. Somatic disruption of FA/BRCA genes occurs in malignancies in non-FA patients, including leukemia 12, 13, 78, 79 , cervical 10 , ovarian 11, 80, 81 , breast 82 , bladder 83 and lung cancers 84 . Our analysis of the COSMIC 85 database revealed multiple cancer-associated FANCA and FANCC-inactivating mutations in non-FA patients (Supplemental Figure 13) . Since FA−/− cells are hypersensitive to antimitotics, future preclinical studies will determine whether targeting mitosis can be employed in FA-deficient cancers. This strategy may complement other evidence-driven precision medicine efforts against FA−/− cancers, such as targeting PARP-dependent DNA repair pathways [86] [87] [88] , DNA damage kinases 89 and selective use of crosslinkers 11, 68 . 
